{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:35:58Z","timestamp":1788287758495,"version":"build-2803163510"},"reference-count":77,"publisher":"BMJ","funder":[{"name":"Danish Cardiovascular Academy, funded by Novo Nordisk Foundation","award":["NNF17SA0031406"],"award-info":[{"award-number":["NNF17SA0031406"]}]},{"name":"Danish Cardiovascular Academy, funded by Novo Nordisk Foundation","award":["NNF20SA0067242"],"award-info":[{"award-number":["NNF20SA0067242"]}]},{"DOI":"10.13039\/100007405","name":"Danish Heart Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2025,10,27]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute heart failure (AHF) is a severe clinical syndrome associated with high morbidity and mortality. Effective management of congestion is a primary treatment goal and often requires hospitalisation. While loop-diuretics remain the cornerstone of AHF therapy, the optimal combination of diuretics to an effective decongestion remains uncertain. This systematic review aims to evaluate the efficacy and safety of various diuretic combinations compared with usual care in AHF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The search was conducted across the databases: Medline, Embase, Latin American and Caribbean Health Sciences Literature, Web of Science, Scopus and The Cochrane Central Register of Controlled Trials. Network meta-analysis was used to compare the relative efficacy of different diuretic combinations. Trial sequential analysis (TSA) was conducted to evaluate the sufficiency of cumulative evidence for definitive conclusions. Risk of bias was assessed using the Cochrane Risk of Bias tool for randomised trials V.2. Statistical heterogeneity was evaluated via visual inspection of forest plots through the\n                      <jats:italic>I\u00b2<\/jats:italic>\n                      statistic. The primary outcome was all-cause mortality, and secondary outcomes included serious adverse events (SAEs), hospital readmissions and kidney failure. Exploratory outcomes included changes in body weight and urinary output.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      35 randomised clinical trials involving 11\u2009743 patients were included. In pairwise meta-analyses, none of the diuretics demonstrated an influence on all-cause mortality, SAEs, hospital readmissions or kidney failure. Likewise, TSA showed no influence of combination therapy on mortality. Aggregate data meta-analyses revealed that combinations involving acetazolamide (\u22122.60\u2009kg; 95%\u2009CI \u22124.23 to \u22120.97; p&lt;0.001;\n                      <jats:italic>\n                        I\n                        <jats:sup>2<\/jats:sup>\n                        =\n                      <\/jats:italic>\n                      0.00%), thiazides (\u22120.80\u2009kg; 95%\u2009CI \u22121.40 to \u22120.21; p=0.01;\n                      <jats:italic>\n                        I\n                        <jats:sup>2<\/jats:sup>\n                        =\n                      <\/jats:italic>\n                      38.53%) and vaptans (\u22121.00\u2009kg; 95%\u2009CI \u22121.53 to \u22120.48; p\n                      <jats:italic>&lt;<\/jats:italic>\n                      0.001;\n                      <jats:italic>\n                        I\n                        <jats:sup>2<\/jats:sup>\n                        =\n                      <\/jats:italic>\n                      89.53%) caused significant in-hospital body weight reduction, indicating enhanced decongestion. Network meta-analysis showed similar results, and TSA indicated that there was enough information to accept secondary diuretics influencing decongestion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combination diuretic therapy improves short-term decongestion but does not reduce all-cause mortality, SAEs, hospital readmissions or kidney failure in patients with AHF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/heartjnl-2025-326601","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:20:17Z","timestamp":1763058017000},"page":"heartjnl-2025-326601","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Combinations of diuretics for acute heart failure: a systematic review with network meta-analysis and trial sequential analysis"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0987-5047","authenticated-orcid":false,"given":"Nihal","family":"Nahiz","sequence":"first","affiliation":[{"name":"Department of Cardiology, Hvidovre Hospital, Hvidovre, Denmark"},{"name":"University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus Christian","family":"Jakobsen","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital \u2013 Rigshospitalet, Copenhagen, Denmark"},{"name":"Department of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin Dam","family":"Lukoschewitz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hvidovre Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Doleman","sequence":"additional","affiliation":[{"name":"University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne Juul","family":"Petersen","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital \u2013 Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekim","family":"Seven","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hvidovre Hospital, Hvidovre, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7783-7357","authenticated-orcid":false,"given":"Anne Sophie Overgaard","family":"Olesen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Cardiology, Frederiksberg and Bispebjerg Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina Cecilia","family":"Miger","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"},{"name":"Department of Cardiology, Frederiksberg and Bispebjerg Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Henriette","family":"Tonning","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hvidovre Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"El-Sheikh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hvidovre Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora Olsen","family":"El Caidi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hvidovre Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Dahlgaard","family":"Hove","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hvidovre Hospital, Hvidovre, Denmark"},{"name":"Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Jakob","family":"Thune","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hvidovre Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Grand","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hvidovre Hospital, Hvidovre, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"2025111310200839000_heartjnl-2025-326601v1.1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2025111310200839000_heartjnl-2025-326601v1.2","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11113112","article-title":"Efficacy of Nondiuretic Pharmacotherapy for Improving the Treatment of Congestion in Patients with Acute Heart Failure: A Systematic Review of Randomised Controlled Trials","volume":"11","author":"Emara","year":"2022","journal-title":"J Clin Med"},{"key":"2025111310200839000_heartjnl-2025-326601v1.3","first-page":"2971","article-title":"Comparison of diuretic strategies in diuretic-resistant acute heart failure: a systematic review and network meta-analysis","volume":"25","author":"Orso","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025111310200839000_heartjnl-2025-326601v1.4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/aas.14130","article-title":"Vasodilators for acute heart failure-A protocol for a systematic review of randomized clinical trials with meta-analysis and Trial Sequential Analysis","volume":"66","author":"Grand","year":"2022","journal-title":"Acta Anaesthesiol Scand"},{"key":"2025111310200839000_heartjnl-2025-326601v1.5","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ehf2.12677","article-title":"Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature","volume":"7","author":"Wierda","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2025111310200839000_heartjnl-2025-326601v1.6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/anae.14038","article-title":"Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta\u2010analysis of randomised controlled trials","volume":"73","author":"Ng","year":"2018","journal-title":"Anaesthesia"},{"key":"2025111310200839000_heartjnl-2025-326601v1.7","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ejhf.1307","article-title":"Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial","volume":"20","author":"Mullens","year":"2018","journal-title":"European J of Heart Fail"},{"key":"2025111310200839000_heartjnl-2025-326601v1.8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac689"},{"key":"2025111310200839000_heartjnl-2025-326601v1.9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad341"},{"key":"2025111310200839000_heartjnl-2025-326601v1.10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ejhf.1713","article-title":"Randomized, double\u2010blind, placebo\u2010controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA\u2010RESPONSE\u2010AHF)","volume":"22","author":"Damman","year":"2020","journal-title":"European J of Heart Fail"},{"key":"2025111310200839000_heartjnl-2025-326601v1.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.12.1319"},{"key":"2025111310200839000_heartjnl-2025-326601v1.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.09.012"},{"key":"2025111310200839000_heartjnl-2025-326601v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.09.004"},{"key":"2025111310200839000_heartjnl-2025-326601v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(20)31805-2"},{"key":"2025111310200839000_heartjnl-2025-326601v1.15","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1369"},{"key":"2025111310200839000_heartjnl-2025-326601v1.16","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.289"},{"key":"2025111310200839000_heartjnl-2025-326601v1.17","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/ejhf.1753","article-title":"Clinical importance of urinary sodium excretion in acute heart failure","volume":"22","author":"Damman","year":"2020","journal-title":"European J of Heart Fail"},{"key":"2025111310200839000_heartjnl-2025-326601v1.18","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.197"},{"key":"2025111310200839000_heartjnl-2025-326601v1.19","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.71.2.146"},{"key":"2025111310200839000_heartjnl-2025-326601v1.20","first-page":"1794","article-title":"Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial","volume":"69","author":"Salahudin","year":"2019","journal-title":"J Pak Med Assoc"},{"key":"2025111310200839000_heartjnl-2025-326601v1.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-081890","article-title":"Combination of diuretics for acute heart failure: a protocol for a systematic review of randomised clinical trials with network meta-analysis and trial sequential analysis","volume":"14","author":"Nahiz","year":"2024","journal-title":"BMJ Open"},{"key":"2025111310200839000_heartjnl-2025-326601v1.22","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"2025111310200839000_heartjnl-2025-326601v1.23","unstructured":"Higgins J , Thomas J , Chandler J , et al . Cochrane handbook for systematic reviews of interventions version 6.4. 2023. Available: www.training.cochrane.org\/handbook"},{"key":"2025111310200839000_heartjnl-2025-326601v1.24","unstructured":"ICHGCP . ICH harmonised guideline integrated addendum to ICH E6(R1): guideline for good clinical practice ICH E6(R2) ICH consensus guideline. Available: https:\/\/ichgcp.net\/da\/home [Accessed 12 Oct 2023]."},{"key":"2025111310200839000_heartjnl-2025-326601v1.25","unstructured":"Covidence . Covidence - better systematic review management. Available: https:\/\/www.covidence.org\/ [Accessed 03 Mar 2024]."},{"key":"2025111310200839000_heartjnl-2025-326601v1.26","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2025111310200839000_heartjnl-2025-326601v1.27","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"2025111310200839000_heartjnl-2025-326601v1.28","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780060325"},{"key":"2025111310200839000_heartjnl-2025-326601v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2015.09.002"},{"key":"2025111310200839000_heartjnl-2025-326601v1.30","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"2025111310200839000_heartjnl-2025-326601v1.31","unstructured":"TSA \u2013 ctu.dk . Available: https:\/\/ctu.dk\/tsa\/ [Accessed 22 Nov 2023]."},{"key":"2025111310200839000_heartjnl-2025-326601v1.32","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-018-0770-1","article-title":"Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis","volume":"7","author":"Castellini","year":"2018","journal-title":"Syst Rev"},{"key":"2025111310200839000_heartjnl-2025-326601v1.33","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bja.2024.12.039","article-title":"Methodologies for network meta-analysis of randomised controlled trials in pain, anaesthesia, and perioperative medicine: a narrative review","volume":"134","author":"Doleman","year":"2025","journal-title":"Br J Anaesth"},{"key":"2025111310200839000_heartjnl-2025-326601v1.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: An approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLoS Med"},{"key":"2025111310200839000_heartjnl-2025-326601v1.35","doi-asserted-by":"crossref","DOI":"10.1002\/cl2.1080","article-title":"CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Syst Rev"},{"key":"2025111310200839000_heartjnl-2025-326601v1.36","unstructured":"CINeMA: software for semiautomated assessment of the confidence in the results of network meta\u2010analysis - papakonstantinou - 2020 - campbell systematic reviews - wiley online library. Available: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/cl2.1080 [Accessed 22 Feb 2024]."},{"key":"2025111310200839000_heartjnl-2025-326601v1.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.10.007"},{"key":"2025111310200839000_heartjnl-2025-326601v1.38","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyn188"},{"key":"2025111310200839000_heartjnl-2025-326601v1.39","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in Acute Decompensated Heart Failure with Volume Overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N Engl J Med"},{"key":"2025111310200839000_heartjnl-2025-326601v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.08.013"},{"key":"2025111310200839000_heartjnl-2025-326601v1.41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.cardfail.2016.02.007","article-title":"Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction","volume":"22","author":"Matsue","year":"2016","journal-title":"J Card Fail"},{"key":"2025111310200839000_heartjnl-2025-326601v1.42","article-title":"Diuretic, natriuretic, and chloride-regaining effects of oral acetazolamide as an add-on therapy for acute heart failure with volume overload: a single-center, prospective, randomized study","volume":"133","author":"Kosiorek","year":"2023","journal-title":"Pol Arch Intern Med"},{"key":"2025111310200839000_heartjnl-2025-326601v1.43","doi-asserted-by":"crossref","unstructured":"Piardi D , Butzke M , Mazzuca A , et al . Effect of adding hydrochlorothiazide to usual treatment of patients with acute decompensated heart failure: a randomized clinical trial. Eur Heart J Acute Cardiovasc Care 2021;10. doi:10.1093\/ehjacc\/zuab020.026","DOI":"10.1093\/ehjacc\/zuab020.026"},{"key":"2025111310200839000_heartjnl-2025-326601v1.44","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007048","article-title":"Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart Failure: A Prospective Randomized Controlled Study","volume":"14","author":"Tamaki","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2025111310200839000_heartjnl-2025-326601v1.45","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ihj.2015.07.006","article-title":"Effect of tolvaptan on acute heart failure with hyponatremia \u2013 A randomized, double blind, controlled clinical trial","volume":"68","author":"Shanmugam","year":"2016","journal-title":"Indian Heart J Teach Ser"},{"key":"2025111310200839000_heartjnl-2025-326601v1.46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1253\/circj.CJ-17-0179","article-title":"Effects of Additive Tolvaptan vs. Increased Furosemide on Heart Failure With Diuretic Resistance and Renal Impairment \u2015 Results From the K-STAR Study \u2015","volume":"82","author":"Inomata","year":"2018","journal-title":"Circ J"},{"key":"2025111310200839000_heartjnl-2025-326601v1.47","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.16.1963"},{"key":"2025111310200839000_heartjnl-2025-326601v1.48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ehjcvp\/pvaa132","article-title":"Efficacy and Safety of Early Initiation of Eplerenone Treatment in Patients with Acute Heart Failure (EARLIER trial): a multicentre, randomized, double-blind, placebo-controlled trial","volume":"8","author":"Asakura","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025111310200839000_heartjnl-2025-326601v1.49","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2025111310200839000_heartjnl-2025-326601v1.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2008.06.003"},{"key":"2025111310200839000_heartjnl-2025-326601v1.51","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cardfail.2022.10.323","article-title":"Impact Of Dapagliflozin Treatment On Serum Sodium Concentration In Acute Decompensated Heart Failure","volume":"29","author":"Charaya","year":"2023","journal-title":"J Card Fail"},{"key":"2025111310200839000_heartjnl-2025-326601v1.52","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001936","article-title":"Impact of dapagliflozin treatment on renal function and diuretics use in acute heart failure: a pilot study","volume":"9","author":"Charaya","year":"2022","journal-title":"Open Heart"},{"key":"2025111310200839000_heartjnl-2025-326601v1.53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ehf2.12088","article-title":"Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure","volume":"3","author":"Jujo","year":"2016","journal-title":"ESC Heart Fail"},{"key":"2025111310200839000_heartjnl-2025-326601v1.54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912613"},{"key":"2025111310200839000_heartjnl-2025-326601v1.55","article-title":"Safety and Efficacy of High Dose Spironolactone in Loop Diuretic Resistant Acute Decompensated Heart Failure","volume":"138","author":"Velagapudi","year":"2018","journal-title":"Circulation"},{"key":"2025111310200839000_heartjnl-2025-326601v1.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.035"},{"key":"2025111310200839000_heartjnl-2025-326601v1.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.07.019"},{"key":"2025111310200839000_heartjnl-2025-326601v1.58","first-page":"700","article-title":"The Efficacy and Safety of Short-Term Tolvaptan Usage in Patients with Acute Decompensated Heart Failure","volume":"38","author":"Lin","year":"2022","journal-title":"Acta Cardiol Sin"},{"key":"2025111310200839000_heartjnl-2025-326601v1.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2008.08.010"},{"key":"2025111310200839000_heartjnl-2025-326601v1.60","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1253\/circj.CJ-16-1122","article-title":"Tolvaptan Reduces the Risk of Worsening Renal Function in Patients With Acute Decompensated Heart Failure and Preserved Left Ventricular Ejection Fraction - Prospective Randomized Controlled Study","volume":"81","author":"Tamaki","year":"2017","journal-title":"Circ J"},{"key":"2025111310200839000_heartjnl-2025-326601v1.61","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/ehf2.12783","article-title":"Tolvaptan vs. furosemide\u2010based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA\u2010AHF)","volume":"7","author":"Ng","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2025111310200839000_heartjnl-2025-326601v1.62","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01659-1"},{"key":"2025111310200839000_heartjnl-2025-326601v1.63","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059038"},{"key":"2025111310200839000_heartjnl-2025-326601v1.64","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2024.02.009","article-title":"Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure","volume":"83","author":"Cox","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2025111310200839000_heartjnl-2025-326601v1.65","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/ejhf.2988","article-title":"Combining loop and thiazide diuretics for acute heart failure across the estimated glomerular filtration rate spectrum: A post\u2010hoc analysis of the clorotic trial","volume":"25","author":"Trull\u00e0s","year":"2023","journal-title":"European J of Heart Fail"},{"key":"2025111310200839000_heartjnl-2025-326601v1.66","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/phar.2440","article-title":"A Systematic Review and Meta-Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure","volume":"40","author":"Steuber","year":"2020","journal-title":"Pharmacotherapy"},{"key":"2025111310200839000_heartjnl-2025-326601v1.67","doi-asserted-by":"crossref","unstructured":"Luo X , Jin Q , Wu Y . Tolvaptan add\u2010on therapy in patients with acute heart failure: A systematic review and meta\u2010analysis. Pharmacol Res Perspect 2020;8. doi:10.1002\/prp2.614","DOI":"10.1002\/prp2.614"},{"key":"2025111310200839000_heartjnl-2025-326601v1.68","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1177\/0300060519882221","article-title":"Tolvaptan in reversing worsening acute heart failure: A systematic review and meta-analysis","volume":"47","author":"Wang","year":"2019","journal-title":"J Int Med Res"},{"key":"2025111310200839000_heartjnl-2025-326601v1.69","doi-asserted-by":"crossref","unstructured":"Pratama V , Budiono J , Thobari JA , et al . The role of tolvaptan add-on therapy in patients with acute heart failure: a systematic review and network meta-analysis. Front Cardiovasc Med 2024;11. doi:10.3389\/fcvm.2024.1367442","DOI":"10.3389\/fcvm.2024.1367442"},{"key":"2025111310200839000_heartjnl-2025-326601v1.70","article-title":"Combination Diuretic Therapy With Thiazides: A Systematic Review on the Beneficial Approach to Overcome Refractory Fluid Overload in Heart Failure","volume":"15","author":"Gogikar","year":"2023","journal-title":"Cureus"},{"key":"2025111310200839000_heartjnl-2025-326601v1.71","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10741-024-10417-7","article-title":"Acetazolamide therapy in patients with acute heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"29","author":"Milbradt","year":"2024","journal-title":"Heart Fail Rev"},{"key":"2025111310200839000_heartjnl-2025-326601v1.72","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40256-024-00633-9","article-title":"Acetazolamide as an Adjunctive Diuretic Therapy for Patients with Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis","volume":"24","author":"Siddiqi","year":"2024","journal-title":"Am J Cardiovasc Drugs"},{"key":"2025111310200839000_heartjnl-2025-326601v1.73","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00059-017-4563-4","article-title":"Use of tolvaptan vs. furosemide in older patients with heart failure : Meta-analysis of randomized controlled trials","volume":"43","author":"Huang","year":"2018","journal-title":"Herz"},{"key":"2025111310200839000_heartjnl-2025-326601v1.74","article-title":"Combination diuretic therapies in heart failure: Insights from GUIDE-IT","volume":"45","author":"Budweg","year":"2024","journal-title":"Am Heart J Plus"},{"key":"2025111310200839000_heartjnl-2025-326601v1.75","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.10565"},{"key":"2025111310200839000_heartjnl-2025-326601v1.76","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/aje\/kwaa205","article-title":"Meta-Analysis and Sparse-Data Bias","volume":"190","author":"Richardson","year":"2021","journal-title":"Am J Epidemiol"},{"key":"2025111310200839000_heartjnl-2025-326601v1.77","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i1981","article-title":"Sparse data bias: a problem hiding in plain sight","volume":"352","author":"Greenland","year":"2016","journal-title":"BMJ"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2025-326601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:20:29Z","timestamp":1763058029000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2025-326601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":77,"alternative-id":["10.1136\/heartjnl-2025-326601"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2025-326601","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}